Tuberculosis Bacteria’s Hidden Trick: How They Evade Immune Cells

Scientists have uncovered a sophisticated mechanism used by Mycobacterium tuberculosis, the bacteria that causes tuberculosis (TB), to evade the human immune system and survive within cells. The discovery, presented at the 70th Biophysical Society Annual Meeting in San Francisco, could pave the way for new strategies to combat this deadly infectious disease.

TB remains a major global health crisis, particularly in Asia, Africa, and Latin America, despite the availability of treatment for decades. Its persistence is linked to the lengthy treatment duration and the emergence of antibiotic-resistant strains. More than a million people die from TB each year.

The research reveals that TB bacteria release tiny packages called extracellular vesicles. These vesicles fuse with the membranes of immune cells, specifically macrophages, which are responsible for engulfing and destroying microbes. The vesicles contain specialized lipids – fatty molecules – that increase the rigidity of the cell membrane.

Normally, when immune cells engulf harmful bacteria, they trap them within a compartment called a phagosome. This phagosome then merges with another compartment, the lysosome, which contains digestive enzymes that break down and destroy the bacteria. However, the study found that by stiffening the phagosome membrane, the bacteria prevent this crucial fusion from occurring, effectively creating a protective haven within the immune cell itself.

“If the membrane becomes more rigid, it becomes much more difficult for the phagosome to fuse with the lysosome,” explained Ayush Panda, a researcher involved in the study, formerly at the National Institute of Science Education and Research in India. “It’s an elegant biophysical mechanism; the bacteria are reshaping the architecture of the membrane to escape the process that was supposed to kill it.”

The impact of these vesicles extends beyond the directly infected cells. Researchers found that they can also affect neighboring immune cells, weakening them even before they come into contact with the bacteria. This may contribute to the spread of infection within tissues.

This discovery offers a new perspective on how TB bacteria persist within the body. Previous research has largely focused on the proteins manipulated by the bacteria inside the host cell. This new study takes a different approach, focusing on lipids, and demonstrates that introducing bacterial lipids into host cell membranes is sufficient to disrupt immune function.

“What was most surprising to us was that when we introduced lipids from Mycobacterium tuberculosis into membranes mimicking the host’s phagosome, we observed significant physical changes. The entire membrane’s properties were altered,” Panda said.

Interestingly, the researchers observed similar effects of extracellular vesicles on membranes in other bacteria, such as Klebsiella pneumoniae and Staphylococcus aureus. This suggests that this strategy may be evolutionarily conserved across several pathogens, broadening the implications of the findings. It indicates that manipulating cell membrane properties may be a common weapon in the arsenal of disease-causing bacteria.

The findings open several promising avenues for developing new treatments. Potential strategies include targeting the proteins responsible for producing the bacterial vesicles, or finding ways to counteract the effect of increased membrane rigidity.

“Now that we understand how the bacteria protect themselves, we can start looking for ways to stop them,” Panda stated. “If we can prevent them from increasing the rigidity of those membranes, our immune cells may be able to perform their function and stop the infection.”

The research also highlights the complexity of the immune response to TB. The bacteria don’t simply evade destruction; they actively remodel the environment within the immune cell to create a more hospitable niche for survival. This understanding is crucial for developing more effective therapies that can overcome these bacterial defenses.

Within the body, TB can enter a kind of “sleep mode” inside a structure called a granuloma, slowing its metabolism and becoming incredibly difficult to kill. A granuloma is formed when immune cells surround and trap the bacteria in a tight cluster, preventing the infection from spreading but not necessarily eliminating it. This process involves both innate and adaptive immune cells, creating a biological fortress around the bacteria.